(Q43039715)

English

The combination of interferon alpha-2b and n-butyl deoxynojirimycin has a greater than additive antiviral effect upon production of infectious bovine viral diarrhea virus (BVDV) in vitro: implications for hepatitis C virus (HCV) therapy

scientific article published in September 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

12 November 2017

The combination of interferon alpha-2b and n-butyl deoxynojirimycin has a greater than additive antiviral effect upon production of infectious bovine viral diarrhea virus (BVDV) in vitro: implications for hepatitis C virus (HCV) therapy (English)

1 reference

Europe PubMed Central

12 November 2017

0 references

Hepatitis C virus

1 reference

based on heuristic

inferred from title

5

object named as

Robert Jordan

1 reference

Europe PubMed Central

12 November 2017

author name string

Serguey Ouzounov

1

1 reference

Europe PubMed Central

12 November 2017

Anand Mehta

2

1 reference

Europe PubMed Central

12 November 2017

Raymond A Dwek

3

1 reference

Europe PubMed Central

12 November 2017

Timothy M Block

4

1 reference

Europe PubMed Central

12 November 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 September 2002

1 reference

Europe PubMed Central

12 November 2017

Antiviral Research

1 reference

Europe PubMed Central

12 November 2017

55

1 reference

Europe PubMed Central

12 November 2017

3

1 reference

Europe PubMed Central

12 November 2017

425-435

1 reference

Europe PubMed Central

12 November 2017

Replication of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900075-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Tolerance and efficacy of oral ribavirin treatment of chronic hepatitis C: a multicenter trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900075-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised controlled trial of interferon alfa 2A (rbe) (Roferon-A) for the treatment of chronic hepatitis B virus (HBV) infection: factors that influence response

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900075-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Alpha-glucosidase inhibitors reduce dengue virus production by affecting the initial steps of virion morphogenesis in the endoplasmic reticulum

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900075-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900075-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Study of the mechanism of antiviral action of iminosugar derivatives against bovine viral diarrhea virus

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900075-X

7 January 2021

based on heuristic

inferred from DOI database lookup

N-butyldeoxynojirimycin-mediated inhibition of human immunodeficiency virus entry correlates with changes in antibody recognition of the V1/V2 region of gp120

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900075-X

7 January 2021

based on heuristic

inferred from DOI database lookup

N-butyldeoxynojirimycin-mediated inhibition of human immunodeficiency virus entry correlates with impaired gp120 shedding and gp41 exposure

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900075-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900075-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: molecular mechanisms of kinase regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900075-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Bad time for Bonzo? Experimental models of hepatitis C virus infection, replication, and pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900075-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Three-drug synergistic inhibition of HIV-1 replication in vitro by zidovudine, recombinant soluble CD4, and recombinant interferon-alpha A

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900075-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Double-stranded RNA-activated protein kinase mediates virus-induced apoptosis: a new role for an old actor

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900075-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Interferon-alpha in patients with asymptomatic human immunodeficiency virus (HIV) infection. A randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900075-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination therapy for hepatitis C infection

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900075-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Pathogenesis, natural history, treatment, and prevention of hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900075-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of hepatitis B virus DNA replication by imino sugars without the inhibition of the DNA polymerase: therapeutic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900075-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Application of the isobologram technique for the analysis of combined effects with respect to additivity as well as independence

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900075-X

7 January 2021

based on heuristic

inferred from DOI database lookup

A three-dimensional model to analyze drug-drug interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900075-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised, double-blind, placebo-controlled trial of interferon alpha-2b with and without ribavirin for chronic hepatitis C. The Swedish Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900075-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Antiviral actions of interferons

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900075-X

7 January 2021

based on heuristic

inferred from DOI database lookup

The effects of inhibitors of glucosidase I on the formation of Sindbis virus

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900075-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Anti-viral effect of interferon-alpha on bovine viral diarrhea virus

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900075-X

7 January 2021

based on heuristic

inferred from DOI database lookup

The NS5A protein of hepatitis C virus partially inhibits the antiviral activity of interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900075-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900075-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Imino sugars inhibit the formation and secretion of bovine viral diarrhea virus, a pestivirus model of hepatitis C virus: implications for the development of broad spectrum anti-hepatitis virus agents

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900075-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0166-3542(02)00075-X

1 reference

Europe PubMed Central

12 November 2017

1 reference

Europe PubMed Central

12 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43039715&oldid=1978310996"